JPMorgan Chase & Co. (NYSE:JPM) Stock Holdings Boosted by Meridian Financial Partners LLC

Meridian Financial Partners LLC lifted its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 0.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,020 shares of the financial services provider’s stock after acquiring an additional 55 shares during the quarter. JPMorgan Chase & Co. accounts for 1.2% of Meridian Financial Partners LLC’s portfolio, making the stock its 17th largest holding. Meridian Financial Partners LLC’s holdings in JPMorgan Chase & Co. were worth $2,458,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of the stock. SOA Wealth Advisors LLC. grew its position in shares of JPMorgan Chase & Co. by 108.2% in the first quarter. SOA Wealth Advisors LLC. now owns 44,431 shares of the financial services provider’s stock valued at $10,899,000 after purchasing an additional 23,094 shares during the last quarter. Wynn Capital LLC grew its position in JPMorgan Chase & Co. by 23.6% during the first quarter. Wynn Capital LLC now owns 22,574 shares of the financial services provider’s stock worth $5,537,000 after buying an additional 4,310 shares in the last quarter. City Center Advisors LLC acquired a new stake in JPMorgan Chase & Co. during the first quarter worth about $215,000. Wealthcare Capital Partners LLC grew its position in JPMorgan Chase & Co. by 3.4% during the first quarter. Wealthcare Capital Partners LLC now owns 3,481 shares of the financial services provider’s stock worth $854,000 after buying an additional 115 shares in the last quarter. Finally, Barden Capital Management Inc. acquired a new stake in JPMorgan Chase & Co. during the first quarter worth about $1,484,000. 71.55% of the stock is owned by institutional investors.

JPMorgan Chase & Co. Stock Up 1.5%

Shares of JPM opened at $265.81 on Monday. The company has a market capitalization of $738.71 billion, a P/E ratio of 13.47, a PEG ratio of 2.83 and a beta of 1.08. The company has a debt-to-equity ratio of 1.24, a current ratio of 0.88 and a quick ratio of 0.89. JPMorgan Chase & Co. has a one year low of $190.88 and a one year high of $280.25. The business’s 50 day simple moving average is $247.68 and its 200-day simple moving average is $249.96.

JPMorgan Chase & Co. (NYSE:JPM) last announced its earnings results on Friday, April 11th. The financial services provider reported $5.07 EPS for the quarter, topping the consensus estimate of $4.63 by $0.44. The business had revenue of $45.30 billion for the quarter, compared to the consensus estimate of $43.62 billion. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. JPMorgan Chase & Co.’s revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the business earned $4.44 EPS. As a group, sell-side analysts predict that JPMorgan Chase & Co. will post 18.1 EPS for the current fiscal year.

JPMorgan Chase & Co. Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Thursday, July 3rd will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend is Thursday, July 3rd. JPMorgan Chase & Co.’s payout ratio is currently 27.49%.

Insider Buying and Selling

In related news, CEO Troy L. Rohrbaugh sold 25,000 shares of the business’s stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $247.02, for a total value of $6,175,500.00. Following the completion of the transaction, the chief executive officer now owns 133,381 shares in the company, valued at $32,947,774.62. The trade was a 15.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Robin Leopold sold 1,250 shares of the business’s stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $246.92, for a total transaction of $308,650.00. Following the completion of the transaction, the insider now owns 49,127 shares of the company’s stock, valued at $12,130,438.84. This trade represents a 2.48% decrease in their position. The disclosure for this sale can be found here. Insiders sold 101,722 shares of company stock worth $25,599,477 in the last quarter. Insiders own 0.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Cowen reissued a “buy” rating on shares of JPMorgan Chase & Co. in a research report on Tuesday, May 20th. KGI Securities started coverage on JPMorgan Chase & Co. in a report on Sunday, April 13th. They set a “hold” rating on the stock. Bank of America decreased their price objective on JPMorgan Chase & Co. from $285.00 to $284.00 and set a “buy” rating on the stock in a report on Wednesday, April 2nd. Royal Bank of Canada reaffirmed a “hold” rating on shares of JPMorgan Chase & Co. in a report on Monday, June 2nd. Finally, Wall Street Zen raised JPMorgan Chase & Co. from a “sell” rating to a “hold” rating in a report on Wednesday, May 14th. Thirteen investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $267.15.

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate.